Key Insights
The global Laboratory Automation market is poised for significant expansion, projected to reach $17,020 million by 2025, with a robust Compound Annual Growth Rate (CAGR) of 3.1% from 2025 to 2033. This growth is primarily fueled by an escalating demand for precision and efficiency in diagnostic processes, coupled with the increasing complexity of biological research and drug discovery. The healthcare industry's continuous push for enhanced patient outcomes and reduced turnaround times for diagnostic tests further stimulates the adoption of automated solutions. Furthermore, the burgeoning biotechnology and pharmaceutical sectors are investing heavily in advanced laboratory automation to accelerate R&D pipelines, optimize drug development cycles, and ensure stringent quality control. The drive to minimize human error in sensitive laboratory procedures also represents a critical factor propelling market expansion.
Laboratory Automation Market Size (In Billion)
Several key trends are shaping the trajectory of the Laboratory Automation market. The increasing integration of artificial intelligence (AI) and machine learning (ML) into automated workflows is enhancing analytical capabilities and predictive power. Advancements in robotics, software, and microplate readers are leading to more sophisticated and versatile automation platforms. The market is also witnessing a growing demand for customized and integrated automation solutions that can address specific research or diagnostic needs. While the market exhibits strong growth, certain restraints exist, including the high initial investment costs associated with sophisticated automation systems and the need for skilled personnel to operate and maintain them. However, the long-term benefits of increased throughput, improved accuracy, and reduced operational costs are consistently outweighing these challenges, particularly for large-scale research institutions and established diagnostic facilities. The market's segmentation by type, including software, automated workstations, and robotic systems, highlights the diverse range of solutions available to cater to varied laboratory requirements, further underscoring the dynamic nature of this sector.
Laboratory Automation Company Market Share
Report Description: Global Laboratory Automation Market - Forecast to 2033
Unlock the Future of Scientific Discovery: Comprehensive Insights into the Global Laboratory Automation Market
This in-depth market research report offers a definitive analysis of the Laboratory Automation market, a critical and rapidly expanding sector within the life sciences and healthcare industries. Spanning the historical period of 2019–2024 and projecting future growth through 2033, this report provides an indispensable resource for stakeholders seeking to understand market dynamics, identify growth opportunities, and navigate the competitive landscape. With a base year of 2025, our analysis offers granular insights into market size, segment penetration, and technological advancements shaping the future of research and diagnostics.
The global laboratory automation market is experiencing unprecedented growth, driven by the increasing demand for efficiency, accuracy, and throughput in scientific research and clinical diagnostics. This report dives deep into the intricate workings of this market, exploring its current state and projecting its trajectory over the next decade. We meticulously examine the interplay between various market segments, including the vital parent market and its burgeoning child market sub-segments, to provide a holistic view of growth drivers and potential.
Key Segments Covered:
Industry Developments: This report incorporates the latest industry developments, providing a forward-looking perspective on innovations and trends that are set to redefine laboratory operations.
Key Market Players: Featuring insights on industry titans such as BD, Abbott Diagnostics, Olympus, Thermo Fisher Scientific, Roche Holding, Hamilton Robotics, Siemens, Danaher Corporation, Tecan Group, Agilent Technologies, Biomérieux, Perkinelmer, Qiagen, Aurora Biomed, and Biotek Instruments, this report provides a competitive overview essential for strategic decision-making.
Report Highlights:
This report is essential for R&D managers, laboratory directors, purchasing managers, product developers, and strategic planners in the pharmaceutical, biotechnology, healthcare, and academic sectors. Leverage our expert analysis to optimize your laboratory workflows, invest strategically, and stay ahead of the curve in the dynamic laboratory automation industry.
- Application: Hospitals and Diagnostic Laboratories, Research and Academic Institutes, Biotechnology and Pharmaceutical Companies.
- Type: Software, Automated Workstations, Off-The-Shelf Automated Workcells, Microplate Readers, Robotic Systems, Automated Storage & Retrieval Systems, Other Equipments.
- Market Size: Current market valuation and projected growth figures, with detailed segment analysis. Estimated laboratory automation market size in 2025 at $8,950 million.
- CAGR: Comprehensive Compound Annual Growth Rate (CAGR) projections for the forecast period.
- Technological Advancements: Deep dive into AI, ML, robotics, and cloud computing in lab automation.
- Regional Analysis: Identification of dominant regions and countries driving market expansion.
- Regulatory Impact: Analysis of how regulations influence adoption and innovation in clinical laboratory automation.
- Investment Trends: Insights into M&A activities and strategic partnerships within the biotechnology laboratory automation space.
Laboratory Automation Market Dynamics & Structure
The global laboratory automation market is characterized by a moderate to high level of concentration, with a few key players holding significant market shares. Technological innovation is the primary driver, fueled by the relentless pursuit of enhanced precision, reduced error rates, and increased sample throughput in research and diagnostics. Advancements in robotics, artificial intelligence (AI), machine learning (ML), and liquid handling technologies are continuously pushing the boundaries of what's possible in laboratory settings. Stringent regulatory frameworks, particularly in clinical diagnostics, also play a crucial role, mandating higher standards of quality control and data integrity, thereby necessitating the adoption of automated solutions. Competitive product substitutes, though present in manual processes, are increasingly being outpaced by the efficiency and scalability offered by automated systems. End-user demographics are diverse, ranging from large pharmaceutical companies to small research institutes, each with unique needs and adoption cycles for laboratory automation solutions. Mergers and acquisitions (M&A) trends are a significant aspect of market dynamics, with larger corporations acquiring innovative startups to expand their product portfolios and market reach.
- Market Concentration: The top 5 players are estimated to hold approximately 45-50% of the global market share in 2025.
- Technological Innovation Drivers: Miniaturization of instruments, development of intelligent software with AI capabilities, and integration of IoT for remote monitoring are key innovation areas.
- Regulatory Frameworks: Regulations such as FDA (Food and Drug Administration) and IVDR (In Vitro Diagnostic Regulation) are fostering a demand for validated and compliant laboratory automation systems.
- Competitive Product Substitutes: While manual processes still exist, their cost-inefficiency and higher error rates make them less competitive in high-throughput environments.
- End-User Demographics: A growing demand from hospitals and diagnostic laboratories for faster and more accurate patient results is a key driver.
- M&A Trends: Over the past three years (2021-2024), there have been approximately 15-20 significant M&A deals valued at over $100 million each, focusing on acquiring novel automation technologies and expanding geographical presence.
Laboratory Automation Growth Trends & Insights
The global laboratory automation market is poised for robust expansion, driven by a confluence of technological advancements, escalating healthcare demands, and a paradigm shift towards data-driven scientific discovery. In 2025, the market is estimated to be valued at $8,950 million, with projections indicating sustained growth. The adoption rates of automated solutions are accelerating across various segments, particularly within biotechnology and pharmaceutical companies and large hospitals and diagnostic laboratories, as they seek to optimize workflows, reduce turnaround times, and enhance the reliability of their results. Technological disruptions, including the integration of AI and ML algorithms for data analysis and predictive diagnostics, are revolutionizing laboratory operations, moving beyond simple task automation to intelligent decision support. Consumer behavior shifts are also playing a pivotal role; researchers and clinicians are increasingly prioritizing efficiency, cost-effectiveness, and data security, all of which are inherent benefits of advanced laboratory automation systems. The continuous need for high-throughput screening in drug discovery and development, coupled with the growing prevalence of chronic diseases necessitating more frequent and accurate diagnostic testing, underpins the sustained demand for these sophisticated solutions. Furthermore, the drive towards precision medicine, which requires the analysis of vast genomic and proteomic datasets, directly fuels the need for scalable and automated platforms. The pandemic has also highlighted the importance of agile and efficient laboratory operations, leading to increased investments in automation to ensure business continuity and rapid response capabilities.
The market is experiencing a significant transformation with the rise of intelligent automation, where software plays a crucial role in orchestrating complex workflows. This includes advanced scheduling, real-time monitoring, and predictive maintenance, all contributing to a more seamless and efficient laboratory environment. The increasing complexity of scientific research, especially in areas like genomics, proteomics, and cell-based assays, necessitates automated platforms that can handle intricate protocols with high precision and reproducibility. The economic benefits of automation, such as reduced labor costs, minimized waste, and improved resource utilization, are compelling factors for organizations of all sizes. The growing focus on personalized medicine and companion diagnostics also requires sophisticated automation to process large volumes of patient samples for genetic and biomarker analysis. The shift towards integrated laboratory ecosystems, where instruments, software, and data management systems communicate seamlessly, is another key trend. This integration enhances data integrity, facilitates regulatory compliance, and accelerates the pace of scientific discovery. The demand for flexible and modular automation solutions that can be scaled to meet evolving research needs is also on the rise. This adaptability allows organizations to invest in automation incrementally, aligning with their budgetary constraints and project timelines. The increasing availability of off-the-shelf automated workcells, designed for specific applications, further lowers the barrier to entry for many laboratories. The push towards standardization in laboratory procedures also benefits from automation, ensuring consistency and comparability of results across different sites and experiments. This is particularly important in multi-center clinical trials and global research collaborations. The evolution of robotic systems, from basic sample handling to sophisticated assay execution, is another testament to the industry's innovation trajectory.
Dominant Regions, Countries, or Segments in Laboratory Automation
North America, particularly the United States, currently dominates the laboratory automation market, driven by a robust healthcare infrastructure, significant investments in research and development, and a high concentration of leading pharmaceutical and biotechnology companies. The region's strong academic research ecosystem also contributes significantly to the demand for advanced laboratory automation solutions. The presence of major market players like Thermo Fisher Scientific, Abbott Diagnostics, and Danaher Corporation, with their extensive product portfolios and strong sales networks, further solidifies North America's leading position. The U.S. government's sustained funding for scientific research and development, coupled with favorable policies supporting innovation, acts as a powerful catalyst for market growth. The increasing adoption of digital health technologies and the growing emphasis on personalized medicine are also key drivers in this region. The robust reimbursement policies for diagnostic tests further encourage the adoption of automated systems in hospitals and diagnostic laboratories.
- North America: Holds an estimated market share of 35-40% in 2025, driven by strong R&D spending and a high density of biopharma companies.
- Key Drivers in North America:
- High research and development expenditure, particularly in genomics and drug discovery.
- Presence of leading pharmaceutical and biotechnology firms.
- Advanced healthcare infrastructure and widespread adoption of diagnostic technologies.
- Government initiatives supporting scientific research and innovation.
- Growing demand for precision medicine and personalized therapies.
In Europe, the laboratory automation market is also a significant contributor, propelled by advanced healthcare systems, a strong emphasis on scientific research, and a well-established pharmaceutical industry. Countries like Germany, the United Kingdom, and Switzerland are at the forefront of adopting sophisticated automation technologies. The region's commitment to advancing in vitro diagnostics (IVD) through stringent regulatory frameworks like the IVDR fosters a demand for high-quality and compliant laboratory automation systems. The increasing aging population and the corresponding rise in chronic diseases necessitate efficient diagnostic capabilities, thereby driving market expansion. The European Union's funding programs for research and innovation also play a vital role in stimulating the adoption of cutting-edge automation solutions. The focus on translational research and the development of novel therapeutics further bolsters the demand for advanced laboratory equipment.
- Europe: Estimated to hold 25-30% of the global market share in 2025.
- Key Drivers in Europe:
- Well-developed healthcare systems and a focus on public health initiatives.
- Strong presence of leading pharmaceutical and life science companies.
- Supportive regulatory environment for medical devices and diagnostics.
- Increasing investment in life sciences research and innovation.
- Growing demand for automated clinical diagnostics due to aging demographics.
The Asia-Pacific region, particularly China and India, represents the fastest-growing market for laboratory automation. This rapid growth is fueled by an expanding healthcare sector, increasing disposable incomes, a burgeoning biopharmaceutical industry, and government initiatives aimed at upgrading healthcare infrastructure and promoting technological adoption. As these economies mature, there is a growing demand for advanced diagnostic capabilities and efficient research processes, creating substantial opportunities for laboratory automation providers. The rising incidence of infectious diseases and the increasing prevalence of lifestyle-related chronic diseases in the region further amplify the need for efficient diagnostic testing and research. The "Made in China 2025" initiative and similar government-backed programs in other Asian countries are also driving investments in advanced manufacturing and automation technologies, including within the laboratory sector. The cost-effectiveness of automation solutions, combined with the sheer volume of potential users in this densely populated region, makes it a highly attractive market.
- Asia-Pacific: Expected to exhibit the highest CAGR, with an estimated market share of 20-25% in 2025.
- Key Drivers in Asia-Pacific:
- Rapid growth in the healthcare sector and increasing healthcare expenditure.
- Expanding pharmaceutical and biotechnology industries.
- Government initiatives to promote technological adoption and improve healthcare access.
- Large and growing patient population driving demand for diagnostics.
- Rising disposable incomes leading to increased demand for advanced medical services.
Latin America and the Middle East & Africa are emerging markets with significant untapped potential. These regions are characterized by improving healthcare infrastructure, increasing government focus on healthcare modernization, and a growing awareness of the benefits of automation in laboratories. As these economies develop, investments in scientific research and clinical diagnostics are expected to rise, creating new avenues for market expansion.
Laboratory Automation Product Landscape
The laboratory automation product landscape is defined by a diverse array of innovative solutions designed to enhance efficiency and precision. Automated workstations, such as those offered by Thermo Fisher Scientific and Hamilton Robotics, provide integrated platforms for sample preparation, analysis, and data management, significantly reducing manual intervention. Robotic systems, including those from Siemens and Tecan Group, are revolutionizing high-throughput screening and complex assay execution with their precision and scalability. Software solutions are increasingly central, enabling intelligent workflow management, data analysis, and system integration, with companies like Agilent Technologies offering comprehensive software suites. Microplate readers, vital for many biochemical and cell-based assays, continue to evolve with enhanced sensitivity and throughput capabilities from manufacturers like BioTek Instruments. The development of off-the-shelf automated workcells offers standardized, application-specific solutions for common laboratory tasks, further democratizing access to automation.
Key Drivers, Barriers & Challenges in Laboratory Automation
Key Drivers:
- Increasing demand for efficiency and accuracy: Laboratories worldwide are striving to improve throughput and reduce errors, making automation a necessity.
- Advancements in technology: Innovations in robotics, AI, and software are enabling more sophisticated and integrated automation solutions.
- Growth in the pharmaceutical and biotechnology sectors: The need for rapid drug discovery and development fuels demand for high-throughput automation.
- Rising prevalence of chronic diseases: This leads to a greater demand for accurate and timely diagnostic testing, driving automation in clinical labs.
- Cost pressures: Automation can lead to long-term cost savings by reducing labor expenses and minimizing waste.
Barriers & Challenges:
- High initial investment cost: The upfront expenditure for sophisticated automation systems can be prohibitive for smaller laboratories.
- Integration complexity: Integrating new automated systems with existing laboratory infrastructure and LIMS (Laboratory Information Management Systems) can be challenging.
- Need for skilled personnel: Operating and maintaining advanced automation systems requires trained technicians and scientists, leading to a skills gap.
- Regulatory hurdles: Compliance with stringent regulations can add complexity and cost to the validation and implementation of automated systems.
- Resistance to change: Overcoming the inertia of traditional manual processes and fostering a culture of automation adoption can be a significant challenge.
- Supply chain disruptions: Global supply chain issues can impact the availability of critical components for automated systems.
Emerging Opportunities in Laboratory Automation
Emerging opportunities in laboratory automation lie in the expanding application of AI and ML for predictive analytics and intelligent data interpretation, moving beyond mere task execution. The growing demand for point-of-care diagnostics and decentralized testing environments presents a significant opportunity for miniaturized and user-friendly automated platforms. Furthermore, the increasing focus on personalized medicine and genomic analysis necessitates advanced automation for high-throughput sequencing and variant identification. Untapped markets in developing regions, driven by improving healthcare infrastructure and rising R&D investments, offer substantial growth potential. The integration of automation with IoT and cloud-based solutions is creating opportunities for remote monitoring, data sharing, and enhanced collaboration, paving the way for "smart labs."
Growth Accelerators in the Laboratory Automation Industry
Several catalysts are accelerating the growth of the laboratory automation industry. Technological breakthroughs in AI, robotics, and miniaturization are continuously enhancing the capabilities and reducing the cost of automated systems. Strategic partnerships and collaborations between technology providers and research institutions are fostering innovation and accelerating the development of novel applications. Market expansion strategies, including the development of modular and scalable solutions, are making automation more accessible to a wider range of laboratories. The increasing global focus on improving public health outcomes, particularly in the wake of recent pandemics, is driving significant investments in laboratory infrastructure and automation. The growing trend towards outsourcing research and development activities also creates demand for automated solutions from contract research organizations (CROs).
Key Players Shaping the Laboratory Automation Market
- BD
- Abbott Diagnostics
- Olympus
- Thermo Fisher Scientific
- Roche Holding
- Hamilton Robotics
- Siemens
- Danaher Corporation
- Tecan Group
- Agilent Technologies
- Biomérieux
- Perkinelmer
- Qiagen
- Aurora Biomed
- Biotek Instruments
Notable Milestones in Laboratory Automation Sector
- 2019: Launch of advanced robotic liquid handling platforms with enhanced precision and throughput by Hamilton Robotics.
- 2020: Thermo Fisher Scientific introduces new integrated automation solutions for high-throughput molecular testing in response to global health needs.
- 2021: Abbott Diagnostics expands its diagnostics portfolio with automated immunoassay analyzers featuring AI-driven capabilities.
- 2022: Roche Holding announces strategic acquisitions to bolster its presence in the digital pathology and advanced imaging automation space.
- 2022: Tecan Group unveils new modular automation solutions designed for flexibility and scalability in various laboratory applications.
- 2023: Siemens Healthineers launches next-generation automated immunoassay systems with improved efficiency and connectivity for clinical laboratories.
- 2024: Agilent Technologies enhances its software offerings for laboratory automation, focusing on data integrity and AI-powered analysis.
- 2024: Qiagen releases new automated sample preparation systems for genomic and proteomic research, addressing the growing need for high-volume analysis.
In-Depth Laboratory Automation Market Outlook
The laboratory automation market is set for sustained and accelerated growth, driven by an increasing imperative for efficiency, accuracy, and speed in scientific research and clinical diagnostics. Future growth accelerators will be deeply intertwined with advancements in AI and ML, transforming laboratories into intelligent hubs capable of predictive analysis and automated decision-making. The expansion of personalized medicine and the growing volume of genomic and proteomic data will necessitate further innovation in high-throughput screening and analysis automation. Strategic partnerships and the development of integrated, cloud-connected laboratory ecosystems will unlock new levels of collaboration and data utilization. Emerging markets, coupled with the continued drive for technological upgrades in developed regions, present significant untapped potential. The industry's ability to adapt to evolving regulatory landscapes and address persistent challenges like skilled workforce development will be crucial in realizing the full market potential.
Laboratory Automation Segmentation
-
1. Application
- 1.1. Hospitals and Diagnostic Laboratories
- 1.2. Research and Academic Institutes
- 1.3. Biotechnology and Pharmaceutical Companies
-
2. Type
- 2.1. Software
- 2.2. Automated Workstations
- 2.3. Off-The-Shelf Automated Workcells
- 2.4. Microplate Readers
- 2.5. Robotic Systems
- 2.6. Automated Storage & Retrieval Systems
- 2.7. Other Equipments
Laboratory Automation Segmentation By Geography
-
1. North America
- 1.1. United States
- 1.2. Canada
- 1.3. Mexico
-
2. South America
- 2.1. Brazil
- 2.2. Argentina
- 2.3. Rest of South America
-
3. Europe
- 3.1. United Kingdom
- 3.2. Germany
- 3.3. France
- 3.4. Italy
- 3.5. Spain
- 3.6. Russia
- 3.7. Benelux
- 3.8. Nordics
- 3.9. Rest of Europe
-
4. Middle East & Africa
- 4.1. Turkey
- 4.2. Israel
- 4.3. GCC
- 4.4. North Africa
- 4.5. South Africa
- 4.6. Rest of Middle East & Africa
-
5. Asia Pacific
- 5.1. China
- 5.2. India
- 5.3. Japan
- 5.4. South Korea
- 5.5. ASEAN
- 5.6. Oceania
- 5.7. Rest of Asia Pacific
Laboratory Automation Regional Market Share
Geographic Coverage of Laboratory Automation
Laboratory Automation REPORT HIGHLIGHTS
| Aspects | Details |
|---|---|
| Study Period | 2020-2034 |
| Base Year | 2025 |
| Estimated Year | 2026 |
| Forecast Period | 2026-2034 |
| Historical Period | 2020-2025 |
| Growth Rate | CAGR of 9.3% from 2020-2034 |
| Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Objective
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Market Snapshot
- 3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restrains
- 3.3. Market Trends
- 3.4. Market Opportunities
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.2. PESTEL analysis
- 4.3. BCG Analysis
- 4.3.1. Stars (High Growth, High Market Share)
- 4.3.2. Cash Cows (Low Growth, High Market Share)
- 4.3.3. Question Mark (High Growth, Low Market Share)
- 4.3.4. Dogs (Low Growth, Low Market Share)
- 4.4. Ansoff Matrix Analysis
- 4.5. Supply Chain Analysis
- 4.6. Regulatory Landscape
- 4.7. Current Market Potential and Opportunity Assessment (TAM–SAM–SOM Framework)
- 4.8. IMR Analyst Note
- 4.1. Porters Five Forces
- 5. Market Analysis, Insights and Forecast 2021-2033
- 5.1. Market Analysis, Insights and Forecast - by Application
- 5.1.1. Hospitals and Diagnostic Laboratories
- 5.1.2. Research and Academic Institutes
- 5.1.3. Biotechnology and Pharmaceutical Companies
- 5.2. Market Analysis, Insights and Forecast - by Type
- 5.2.1. Software
- 5.2.2. Automated Workstations
- 5.2.3. Off-The-Shelf Automated Workcells
- 5.2.4. Microplate Readers
- 5.2.5. Robotic Systems
- 5.2.6. Automated Storage & Retrieval Systems
- 5.2.7. Other Equipments
- 5.3. Market Analysis, Insights and Forecast - by Region
- 5.3.1. North America
- 5.3.2. South America
- 5.3.3. Europe
- 5.3.4. Middle East & Africa
- 5.3.5. Asia Pacific
- 5.1. Market Analysis, Insights and Forecast - by Application
- 6. Global Laboratory Automation Analysis, Insights and Forecast, 2021-2033
- 6.1. Market Analysis, Insights and Forecast - by Application
- 6.1.1. Hospitals and Diagnostic Laboratories
- 6.1.2. Research and Academic Institutes
- 6.1.3. Biotechnology and Pharmaceutical Companies
- 6.2. Market Analysis, Insights and Forecast - by Type
- 6.2.1. Software
- 6.2.2. Automated Workstations
- 6.2.3. Off-The-Shelf Automated Workcells
- 6.2.4. Microplate Readers
- 6.2.5. Robotic Systems
- 6.2.6. Automated Storage & Retrieval Systems
- 6.2.7. Other Equipments
- 6.1. Market Analysis, Insights and Forecast - by Application
- 7. North America Laboratory Automation Analysis, Insights and Forecast, 2020-2032
- 7.1. Market Analysis, Insights and Forecast - by Application
- 7.1.1. Hospitals and Diagnostic Laboratories
- 7.1.2. Research and Academic Institutes
- 7.1.3. Biotechnology and Pharmaceutical Companies
- 7.2. Market Analysis, Insights and Forecast - by Type
- 7.2.1. Software
- 7.2.2. Automated Workstations
- 7.2.3. Off-The-Shelf Automated Workcells
- 7.2.4. Microplate Readers
- 7.2.5. Robotic Systems
- 7.2.6. Automated Storage & Retrieval Systems
- 7.2.7. Other Equipments
- 7.1. Market Analysis, Insights and Forecast - by Application
- 8. South America Laboratory Automation Analysis, Insights and Forecast, 2020-2032
- 8.1. Market Analysis, Insights and Forecast - by Application
- 8.1.1. Hospitals and Diagnostic Laboratories
- 8.1.2. Research and Academic Institutes
- 8.1.3. Biotechnology and Pharmaceutical Companies
- 8.2. Market Analysis, Insights and Forecast - by Type
- 8.2.1. Software
- 8.2.2. Automated Workstations
- 8.2.3. Off-The-Shelf Automated Workcells
- 8.2.4. Microplate Readers
- 8.2.5. Robotic Systems
- 8.2.6. Automated Storage & Retrieval Systems
- 8.2.7. Other Equipments
- 8.1. Market Analysis, Insights and Forecast - by Application
- 9. Europe Laboratory Automation Analysis, Insights and Forecast, 2020-2032
- 9.1. Market Analysis, Insights and Forecast - by Application
- 9.1.1. Hospitals and Diagnostic Laboratories
- 9.1.2. Research and Academic Institutes
- 9.1.3. Biotechnology and Pharmaceutical Companies
- 9.2. Market Analysis, Insights and Forecast - by Type
- 9.2.1. Software
- 9.2.2. Automated Workstations
- 9.2.3. Off-The-Shelf Automated Workcells
- 9.2.4. Microplate Readers
- 9.2.5. Robotic Systems
- 9.2.6. Automated Storage & Retrieval Systems
- 9.2.7. Other Equipments
- 9.1. Market Analysis, Insights and Forecast - by Application
- 10. Middle East & Africa Laboratory Automation Analysis, Insights and Forecast, 2020-2032
- 10.1. Market Analysis, Insights and Forecast - by Application
- 10.1.1. Hospitals and Diagnostic Laboratories
- 10.1.2. Research and Academic Institutes
- 10.1.3. Biotechnology and Pharmaceutical Companies
- 10.2. Market Analysis, Insights and Forecast - by Type
- 10.2.1. Software
- 10.2.2. Automated Workstations
- 10.2.3. Off-The-Shelf Automated Workcells
- 10.2.4. Microplate Readers
- 10.2.5. Robotic Systems
- 10.2.6. Automated Storage & Retrieval Systems
- 10.2.7. Other Equipments
- 10.1. Market Analysis, Insights and Forecast - by Application
- 11. Asia Pacific Laboratory Automation Analysis, Insights and Forecast, 2020-2032
- 11.1. Market Analysis, Insights and Forecast - by Application
- 11.1.1. Hospitals and Diagnostic Laboratories
- 11.1.2. Research and Academic Institutes
- 11.1.3. Biotechnology and Pharmaceutical Companies
- 11.2. Market Analysis, Insights and Forecast - by Type
- 11.2.1. Software
- 11.2.2. Automated Workstations
- 11.2.3. Off-The-Shelf Automated Workcells
- 11.2.4. Microplate Readers
- 11.2.5. Robotic Systems
- 11.2.6. Automated Storage & Retrieval Systems
- 11.2.7. Other Equipments
- 11.1. Market Analysis, Insights and Forecast - by Application
- 12. Competitive Analysis
- 12.1. Company Profiles
- 12.1.1 BD
- 12.1.1.1. Company Overview
- 12.1.1.2. Products
- 12.1.1.3. Company Financials
- 12.1.1.4. SWOT Analysis
- 12.1.2 Abbott Diagnostics
- 12.1.2.1. Company Overview
- 12.1.2.2. Products
- 12.1.2.3. Company Financials
- 12.1.2.4. SWOT Analysis
- 12.1.3 Olympus
- 12.1.3.1. Company Overview
- 12.1.3.2. Products
- 12.1.3.3. Company Financials
- 12.1.3.4. SWOT Analysis
- 12.1.4 Thermo Fisher Scientific
- 12.1.4.1. Company Overview
- 12.1.4.2. Products
- 12.1.4.3. Company Financials
- 12.1.4.4. SWOT Analysis
- 12.1.5 Roche Holding
- 12.1.5.1. Company Overview
- 12.1.5.2. Products
- 12.1.5.3. Company Financials
- 12.1.5.4. SWOT Analysis
- 12.1.6 Hamilton Robotics
- 12.1.6.1. Company Overview
- 12.1.6.2. Products
- 12.1.6.3. Company Financials
- 12.1.6.4. SWOT Analysis
- 12.1.7 Siemens
- 12.1.7.1. Company Overview
- 12.1.7.2. Products
- 12.1.7.3. Company Financials
- 12.1.7.4. SWOT Analysis
- 12.1.8 Danaher Corporation
- 12.1.8.1. Company Overview
- 12.1.8.2. Products
- 12.1.8.3. Company Financials
- 12.1.8.4. SWOT Analysis
- 12.1.9 Tecan Group
- 12.1.9.1. Company Overview
- 12.1.9.2. Products
- 12.1.9.3. Company Financials
- 12.1.9.4. SWOT Analysis
- 12.1.10 Agilent Technologies
- 12.1.10.1. Company Overview
- 12.1.10.2. Products
- 12.1.10.3. Company Financials
- 12.1.10.4. SWOT Analysis
- 12.1.11 Biomérieux
- 12.1.11.1. Company Overview
- 12.1.11.2. Products
- 12.1.11.3. Company Financials
- 12.1.11.4. SWOT Analysis
- 12.1.12 Perkinelmer
- 12.1.12.1. Company Overview
- 12.1.12.2. Products
- 12.1.12.3. Company Financials
- 12.1.12.4. SWOT Analysis
- 12.1.13 Qiagen
- 12.1.13.1. Company Overview
- 12.1.13.2. Products
- 12.1.13.3. Company Financials
- 12.1.13.4. SWOT Analysis
- 12.1.14 Aurora Biomed
- 12.1.14.1. Company Overview
- 12.1.14.2. Products
- 12.1.14.3. Company Financials
- 12.1.14.4. SWOT Analysis
- 12.1.15 Biotek Instruments
- 12.1.15.1. Company Overview
- 12.1.15.2. Products
- 12.1.15.3. Company Financials
- 12.1.15.4. SWOT Analysis
- 12.1.1 BD
- 12.2. Market Entropy
- 12.2.1 Company's Key Areas Served
- 12.2.2 Recent Developments
- 12.3. Company Market Share Analysis 2025
- 12.3.1 Top 5 Companies Market Share Analysis
- 12.3.2 Top 3 Companies Market Share Analysis
- 12.4. List of Potential Customers
- 13. Research Methodology
List of Figures
- Figure 1: Global Laboratory Automation Revenue Breakdown (billion, %) by Region 2025 & 2033
- Figure 2: North America Laboratory Automation Revenue (billion), by Application 2025 & 2033
- Figure 3: North America Laboratory Automation Revenue Share (%), by Application 2025 & 2033
- Figure 4: North America Laboratory Automation Revenue (billion), by Type 2025 & 2033
- Figure 5: North America Laboratory Automation Revenue Share (%), by Type 2025 & 2033
- Figure 6: North America Laboratory Automation Revenue (billion), by Country 2025 & 2033
- Figure 7: North America Laboratory Automation Revenue Share (%), by Country 2025 & 2033
- Figure 8: South America Laboratory Automation Revenue (billion), by Application 2025 & 2033
- Figure 9: South America Laboratory Automation Revenue Share (%), by Application 2025 & 2033
- Figure 10: South America Laboratory Automation Revenue (billion), by Type 2025 & 2033
- Figure 11: South America Laboratory Automation Revenue Share (%), by Type 2025 & 2033
- Figure 12: South America Laboratory Automation Revenue (billion), by Country 2025 & 2033
- Figure 13: South America Laboratory Automation Revenue Share (%), by Country 2025 & 2033
- Figure 14: Europe Laboratory Automation Revenue (billion), by Application 2025 & 2033
- Figure 15: Europe Laboratory Automation Revenue Share (%), by Application 2025 & 2033
- Figure 16: Europe Laboratory Automation Revenue (billion), by Type 2025 & 2033
- Figure 17: Europe Laboratory Automation Revenue Share (%), by Type 2025 & 2033
- Figure 18: Europe Laboratory Automation Revenue (billion), by Country 2025 & 2033
- Figure 19: Europe Laboratory Automation Revenue Share (%), by Country 2025 & 2033
- Figure 20: Middle East & Africa Laboratory Automation Revenue (billion), by Application 2025 & 2033
- Figure 21: Middle East & Africa Laboratory Automation Revenue Share (%), by Application 2025 & 2033
- Figure 22: Middle East & Africa Laboratory Automation Revenue (billion), by Type 2025 & 2033
- Figure 23: Middle East & Africa Laboratory Automation Revenue Share (%), by Type 2025 & 2033
- Figure 24: Middle East & Africa Laboratory Automation Revenue (billion), by Country 2025 & 2033
- Figure 25: Middle East & Africa Laboratory Automation Revenue Share (%), by Country 2025 & 2033
- Figure 26: Asia Pacific Laboratory Automation Revenue (billion), by Application 2025 & 2033
- Figure 27: Asia Pacific Laboratory Automation Revenue Share (%), by Application 2025 & 2033
- Figure 28: Asia Pacific Laboratory Automation Revenue (billion), by Type 2025 & 2033
- Figure 29: Asia Pacific Laboratory Automation Revenue Share (%), by Type 2025 & 2033
- Figure 30: Asia Pacific Laboratory Automation Revenue (billion), by Country 2025 & 2033
- Figure 31: Asia Pacific Laboratory Automation Revenue Share (%), by Country 2025 & 2033
List of Tables
- Table 1: Global Laboratory Automation Revenue billion Forecast, by Application 2020 & 2033
- Table 2: Global Laboratory Automation Revenue billion Forecast, by Type 2020 & 2033
- Table 3: Global Laboratory Automation Revenue billion Forecast, by Region 2020 & 2033
- Table 4: Global Laboratory Automation Revenue billion Forecast, by Application 2020 & 2033
- Table 5: Global Laboratory Automation Revenue billion Forecast, by Type 2020 & 2033
- Table 6: Global Laboratory Automation Revenue billion Forecast, by Country 2020 & 2033
- Table 7: United States Laboratory Automation Revenue (billion) Forecast, by Application 2020 & 2033
- Table 8: Canada Laboratory Automation Revenue (billion) Forecast, by Application 2020 & 2033
- Table 9: Mexico Laboratory Automation Revenue (billion) Forecast, by Application 2020 & 2033
- Table 10: Global Laboratory Automation Revenue billion Forecast, by Application 2020 & 2033
- Table 11: Global Laboratory Automation Revenue billion Forecast, by Type 2020 & 2033
- Table 12: Global Laboratory Automation Revenue billion Forecast, by Country 2020 & 2033
- Table 13: Brazil Laboratory Automation Revenue (billion) Forecast, by Application 2020 & 2033
- Table 14: Argentina Laboratory Automation Revenue (billion) Forecast, by Application 2020 & 2033
- Table 15: Rest of South America Laboratory Automation Revenue (billion) Forecast, by Application 2020 & 2033
- Table 16: Global Laboratory Automation Revenue billion Forecast, by Application 2020 & 2033
- Table 17: Global Laboratory Automation Revenue billion Forecast, by Type 2020 & 2033
- Table 18: Global Laboratory Automation Revenue billion Forecast, by Country 2020 & 2033
- Table 19: United Kingdom Laboratory Automation Revenue (billion) Forecast, by Application 2020 & 2033
- Table 20: Germany Laboratory Automation Revenue (billion) Forecast, by Application 2020 & 2033
- Table 21: France Laboratory Automation Revenue (billion) Forecast, by Application 2020 & 2033
- Table 22: Italy Laboratory Automation Revenue (billion) Forecast, by Application 2020 & 2033
- Table 23: Spain Laboratory Automation Revenue (billion) Forecast, by Application 2020 & 2033
- Table 24: Russia Laboratory Automation Revenue (billion) Forecast, by Application 2020 & 2033
- Table 25: Benelux Laboratory Automation Revenue (billion) Forecast, by Application 2020 & 2033
- Table 26: Nordics Laboratory Automation Revenue (billion) Forecast, by Application 2020 & 2033
- Table 27: Rest of Europe Laboratory Automation Revenue (billion) Forecast, by Application 2020 & 2033
- Table 28: Global Laboratory Automation Revenue billion Forecast, by Application 2020 & 2033
- Table 29: Global Laboratory Automation Revenue billion Forecast, by Type 2020 & 2033
- Table 30: Global Laboratory Automation Revenue billion Forecast, by Country 2020 & 2033
- Table 31: Turkey Laboratory Automation Revenue (billion) Forecast, by Application 2020 & 2033
- Table 32: Israel Laboratory Automation Revenue (billion) Forecast, by Application 2020 & 2033
- Table 33: GCC Laboratory Automation Revenue (billion) Forecast, by Application 2020 & 2033
- Table 34: North Africa Laboratory Automation Revenue (billion) Forecast, by Application 2020 & 2033
- Table 35: South Africa Laboratory Automation Revenue (billion) Forecast, by Application 2020 & 2033
- Table 36: Rest of Middle East & Africa Laboratory Automation Revenue (billion) Forecast, by Application 2020 & 2033
- Table 37: Global Laboratory Automation Revenue billion Forecast, by Application 2020 & 2033
- Table 38: Global Laboratory Automation Revenue billion Forecast, by Type 2020 & 2033
- Table 39: Global Laboratory Automation Revenue billion Forecast, by Country 2020 & 2033
- Table 40: China Laboratory Automation Revenue (billion) Forecast, by Application 2020 & 2033
- Table 41: India Laboratory Automation Revenue (billion) Forecast, by Application 2020 & 2033
- Table 42: Japan Laboratory Automation Revenue (billion) Forecast, by Application 2020 & 2033
- Table 43: South Korea Laboratory Automation Revenue (billion) Forecast, by Application 2020 & 2033
- Table 44: ASEAN Laboratory Automation Revenue (billion) Forecast, by Application 2020 & 2033
- Table 45: Oceania Laboratory Automation Revenue (billion) Forecast, by Application 2020 & 2033
- Table 46: Rest of Asia Pacific Laboratory Automation Revenue (billion) Forecast, by Application 2020 & 2033
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the Laboratory Automation?
The projected CAGR is approximately 9.3%.
2. Which companies are prominent players in the Laboratory Automation?
Key companies in the market include BD, Abbott Diagnostics, Olympus, Thermo Fisher Scientific, Roche Holding, Hamilton Robotics, Siemens, Danaher Corporation, Tecan Group, Agilent Technologies, Biomérieux, Perkinelmer, Qiagen, Aurora Biomed, Biotek Instruments.
3. What are the main segments of the Laboratory Automation?
The market segments include Application, Type.
4. Can you provide details about the market size?
The market size is estimated to be USD 8.27 billion as of 2022.
5. What are some drivers contributing to market growth?
N/A
6. What are the notable trends driving market growth?
N/A
7. Are there any restraints impacting market growth?
N/A
8. Can you provide examples of recent developments in the market?
N/A
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 3950.00, USD 5925.00, and USD 7900.00 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in billion.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "Laboratory Automation," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the Laboratory Automation report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the Laboratory Automation?
To stay informed about further developments, trends, and reports in the Laboratory Automation, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database
Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)
Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations
Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence